Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

By Y. Persidsky, S. Ramirez, J. Haorah, G. Kanmogne. Journal of Neuroimmune Pharmacology, 2006

886 citations recorded by the source corpus.

Subfields: Neurology, Nutrition and Dietetics, Oncology

View Paper: https://www.semanticscholar.org/paper/eb16d8f7f34b8785e41b80f2f0416dba4c43ae35

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Neurology

In Oncology

Citations in the corpus

The blood-brain barrier in Alzheimer's disease (2017, positive): “…molecules linking the TJ to the actin cyto-skeleton are affected during acute and chronic CNS diseases, suggesting that the modi ﬁ cation of TJ components may contribute to disease pathogenesis (Petty and Lo, 2002; Persidsky et al., 2006; Bednarczyk and Lukasiuk, 2011; Gonçalves et al., 2013).”
A blood–brain barrier overview on structure, function, impairment, and biomarkers of integrity (2020, background): “Still, barrier disturbance can often be seen to contribute to and exacerbate developing pathology [169].”
Cytokine regulation of tight junctions (2008, background): “Cytokinemediated changes in paracellular permeability contribute to a multitude of pathologic conditions including inflammatory bowel disease (IBD), airway inflammation in asthma [1] and cystic fibrosis [2], and diseases that perturb the blood-brain barrier (BBB) [3].”
In vitro microvessels for the study of angiogenesis and thrombosis (2012, background): “These include the effects of geometry (42), hydrodynamic stresses, and transport processes (13, 43) on the stability of vessels, the progression of angiogenesis, and the interactions of the vessel with blood cells; and the roles of vascular cells from different organs in defining physiological and p”
Western Diet Consumption and Cognitive Impairment: Links to Hippocampal Dysfunction and Obesity (2010, background): “The blood-brain barrier (BBB) is a specialized system comprising a microvascular endothelium that limits the entry of many blood components into the brain [89].”
Structure and function of the blood-brain barrier. (2010, background): “Grieshaber and Flammer, 2007 Lysosomal storage diseases (LSD) May show changes in BBB permeability, and/or transport, depending on specific LSD Begley et al., 2008 developing pathology (Persidsky et al., 2006).”
Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases. (2016, background): “involved in the transport of insulin or transferrin, to name a few [10].”
The blood-brain barrier in brain homeostasis and neurological diseases. (2009, neutral): “The BBB is localized at the interface between the blood and the cerebral tissue [1,2], formed by the endothelial cells (ECs) of cerebral blood vessels which display a unique phenotype characterized by the presence of intercellular tight junctions and the polarized expression of numerous transport…”
The blood–brain barrier: Structure, regulation and drug delivery (2023, background): “97 Tricellulin and the lipolysis-stimulated lipoprotein receptor that reside in three-cell contacts are also the major tight junction proteins.”